Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants

Bnai Zion Medical Center

Status and phase: Completed; Phase 1

Conditions: Bronchiolitis

Treatments: Drug: Inhaled Furosemide vs Placebo (Normal Saline)

Study type: Interventional

Funder types: Other

Identifiers

NCT00261937

67/05

Details and patient eligibility

About

We hypothesize that inhaled Furosemide will be an effective treatment in infants with acute bronchiolitis.

Sex: All

Ages: 1 day to 12 months old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age: 0-12 months.
• Infants who are otherwise healthy
• Infants with chronic lung disease of prematurity (BPD) will be included, but will be analyzed separately.
• Parents signed a written informed consent.

Exclusion criteria

• • Other previous or co-morbidity, specifically: respiratory (other than BPD, like Asthma or Cystic Fibrosis), cardiac or renal disease or anomaly.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind